Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy

被引:11
作者
Rosko, Ashley E. [1 ]
Wall, Sarah [1 ]
Baiocchi, Robert [1 ]
Benson, Don M. [1 ]
Brammer, Jonathan E. [1 ]
Byrd, John C. [1 ]
Efebera, Yvonne A. [1 ]
Maddocks, Kami [1 ]
Rogers, Kerry A. [1 ]
Jones, Desiree [1 ]
Sucheston-Campbell, Lara [2 ]
Tang, Hancong [2 ]
Ozer, Hatice Gulcin [3 ]
Huang, Ying [1 ]
Burd, Christin E. [4 ]
Naughton, Michelle J. [5 ]
机构
[1] Ohio State Univ, Div Hematol, A345 Starling Loving Hall,320 West 10th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
[4] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA
[5] Ohio State Univ, Canc Prevent & Control, Columbus, OH 43210 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2021年 / 19卷 / 09期
关键词
QUALITY-OF-LIFE; T-CELLS; CHEMOTHERAPY TOXICITY; GERIATRIC ASSESSMENT; CANCER; MORTALITY; BIOMARKER; OUTCOMES; P16(INK4A); DISABILITY;
D O I
10.6004/jnccn.2020.7686
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gauging fitness remains a challenge among older adults with hematologic malignancies, and interventions to restore function are lacking. We pilot a structured exercise intervention and novel biologic correlates of aging using epigenetic clocks and markers of immunosenescence to evaluate changes in function and clinical outcomes. Methods: Older adults (n=30) with hematologic malignancy actively receiving treatment were screened and enrolled in a 6-month exercise intervention, the Otago Exercise Programme (OEP). The impact of the OEP on geriatric assessment metrics and health-related quality of life were captured. Clinical outcomes of overall survival and hospital utilization (inpatient length of stay and emergency department use) in relationship to geriatric deficits were analyzed. Results: Older adults (median age, 75.5 years [range, 62-83 years]) actively receiving treatment were enrolled in the OEP. Instrumental activities of daily living and physical health scores (PHS) increased significantly with the OEP intervention (median PHS: visit 1, 55 [range, 0-100]; visit 2, 70 [range, 30-100]; P<.01). Patient-reported Karnofsky performance status increased significantly, and the improvement was sustained (median [range]: visit 1, 80 [40-100]; visit 3, 90 [50-100]; P=.05). Quality of life (Patient-Reported Outcome Measurement Information System [PROMIS]) improved significantly by the end of the 6-month period (median [range]: visit 1, 32.4 [19.9-47.7]; visit 3, 36.2 [19.9-47.7]; P=.01]. Enhanced measures of gait speed and balance, using the Short Physical Performance Battery scores, were associated with a 20% decrease in risk of death (hazard ratio, 0.80; 95% CI, 0.65-0.97; P=.03) and a shorter hospital length of stay (decrease of 1.29 days; 95% CI, -2.46 to -0.13; P=.03). Peripheral blood immunosenescent markers were analyzed in relationship to clinical frailty and reports of mPhenoAge epigenetic analysis are preliminarily reported. Chronologic age had no relationship to overall survival, length of stay, or emergency department utilization. Conclusions: The OEP was effective in improving quality of life, and geriatric tools predicted survival and hospital utilization among older adults with hematologic malignancies.
引用
收藏
页码:1027 / +
页数:12
相关论文
共 50 条
  • [1] Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection
    Alter, Galit
    Rihn, Suzannah
    Streeck, Hendrik
    Teigen, Nickolas
    Piechocka-Trocha, Alicja
    Moss, Kristin
    Cohen, Kristen
    Meier, Angela
    Pereyra, Florencia
    Walker, Bruce
    Altfeld, Marcus
    [J]. JOURNAL OF VIROLOGY, 2008, 82 (19) : 9668 - 9677
  • [2] [Anonymous], 2015, SVA SURROGATE VARIAB
  • [3] [Anonymous], 1992, Measuring functioning and well-being: The medical outcomes study EApproach
  • [4] When aging reaches CD4+T-cells: phenotypic and functional changes
    Antonio Moro-Garcia, Marco
    Alonso-Arias, Rebeca
    Lopez-Larrea, Carlos
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [5] Anemia, fatigue and aging
    Balducci, L.
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2010, 17 (5-6) : 375 - 381
  • [6] Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology
    Basch, Ethan
    Abernethy, Amy P.
    Mullins, C. Daniel
    Reeve, Bryce B.
    Smith, Mary Lou
    Coons, Stephen Joel
    Sloan, Jeff
    Wenzel, Keith
    Chauhan, Cynthia
    Eppard, Wayland
    Frank, Elizabeth S.
    Lipscomb, Joseph
    Raymond, Stephen A.
    Spencer, Merianne
    Tunis, Sean
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34) : 4249 - 4255
  • [7] Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1
    Boelen, Lies
    Debebe, Bisrat
    Silveira, Marcos
    Salam, Arafa
    MaKinde, Julia
    Roberts, Chrissy H.
    Wang, Eddie C. Y.
    Frater, John
    Gilmour, Jill
    Twigger, Katie
    Ladell, Kristin
    Miners, Kelly L.
    Jayaraman, Jyothi
    Traherne, James A.
    Price, David A.
    Qi, Ying
    Martin, Maureen P.
    Macallan, Derek C.
    Thio, Chloe L.
    Astemborski, Jacquie
    Kirk, Gregory
    Donfield, Sharyne M.
    Buchbinder, Susan
    Khakoo, Salim, I
    Goedert, James J.
    Trowsdale, John
    Carrington, Mary
    Kollnberger, Simon
    Asquith, Becca
    [J]. SCIENCE IMMUNOLOGY, 2018, 3 (29)
  • [8] Physical function as a prognostic biomarker among cancer survivors
    Brown, J. C.
    Harhay, M. O.
    Harhay, M. N.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (01) : 194 - 198
  • [9] T cell aging: a review of the transcriptional changes determined from genome-wide analysis
    Chen, Guobing
    Lustig, Ana
    Weng, Nan-ping
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [10] T cell subset-specific susceptibility to aging
    Czesnikiewicz-Guzik, Marta
    Lee, Won-Woo
    Cui, Dapeng
    Hiruma, Yuko
    Lamar, David L.
    Yang, Zhi-Zhang
    Ouslander, Joseph G.
    Weyand, Cornelia M.
    Goronzy, Joerg J.
    [J]. CLINICAL IMMUNOLOGY, 2008, 127 (01) : 107 - 118